Vimarsana
Biggest News Aggregation in the World

Page 34 - Ip Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ip Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ip Group Today - Breaking & Trending Today

STORM Therapeutics to present the discovery of lead clinical candidate STC-15 at the American Chemical Society Fall 2023 Conference - Vimarsana News

STORM Therapeutics to present the discovery of lead clinical candidate STC-15 at the American Chemical Society Fall 2023 Conference

/PRNewswire/ -- STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company focused on discovering and developing novel small molecule therapies...

London open: Banks, miners lead the rebound early on - Vimarsana News

London open: Banks, miners lead the rebound early on

Mining and banking stocks led the UK’s benchmark equity index higher on Wednesday morning, rebounding after losses the previous session, despite economic data from China continuing to paint a dreary picture for the world’s second-largest economy.

Thursday preview: US CPI, UK home prices - Vimarsana News

Thursday preview: US CPI, UK home prices

All eyes on Thursday would be on the latest reading for US consumer prices covering the month of July.

STORM Therapeutics publishes data in Cancer Discovery showing induction of anti-tumour immunity by METTL3 inhibition - Vimarsana News

STORM Therapeutics publishes data in Cancer Discovery showing induction of anti-tumour immunity by METTL3 inhibition

/PRNewswire/ -- STORM Therapeutics Ltd. (STORM), a clinical stage biotechnology company focused on discovering and developing novel small molecule therapies...

Week Ahead: US, euro area and China CPI data in focus - Vimarsana News

Week Ahead: US, euro area and China CPI data in focus

Investors' focus over the coming week would be on the latest monthly readings for consumer prices due out in the US, euro area and China.